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Abstract
Objectives
The pathogenesis of sinonasal polyposis remains unclear, in spite of several investigative
approaches. Antrochoanal polyps, a subgroup of sinonasal polyposis along with allergic-
and chronic-inflammatory nasal polyps, mostly originate from the maxillary sinus and
develop as a unilateral, pedunculated mass towards the nasopharynx. The human papillo-
mavirus (HPV) is discussed as a possible causative and influencing factor in development
and progression of sinonasal polyposis. This study aims to elucidate HPV frequency in
nasal polyps and antrochoanal polyps.
Materials and Methods
Genomic DNA from 257 tissue specimens (166 nasal polyps, 39 antrochoanal polyps and
52 nasal turbinates) was subjected to three different established HPV- polymerase chain
reaction assays, testing for 37 low- and high-risk HPV. In addition, immunohistochemical
analyses for HPV16 were carried out, as well as immunohistochemistry and western blots
of p16, a biomarker for HPV induced cancer.
Results
HPV-DNA was detected in 53.8% of antrochoanal polyps, 15.1% of nasal polyps, and 5.8%
of nasal turbinates. HPV16 was the predominant type with a detection rate of 76% in nasal
polyps and 62% in antrochoanal polyps. Immunohistochemically, HPV positive tissues
stained positive for HPV16 antigens and p16 in epithelial cell layers. No significant p16
overexpression was traceable in antrochoanal polyps, nasal polyps and nasal turbinates by
western blot. There was no correlation of HPV-status with sex, age, smoking, alcohol con-
sumption or allergic background.
PLOS ONE | DOI:10.1371/journal.pone.0141722 October 28, 2015 1 / 15
OPEN ACCESS
Citation: Knör M, Tziridis K, Agaimy A, Zenk J,
Wendler O (2015) Human Papillomavirus (HPV)
Prevalence in Nasal and Antrochoanal Polyps and
Association with Clinical Data. PLoS ONE 10(10):
e0141722. doi:10.1371/journal.pone.0141722
Editor: Margaret McLaughlin-Drubin, Brigham and
Women's Hospital/Harvard Medical School, UNITED
STATES
Received: July 24, 2015
Accepted: October 12, 2015
Published: October 28, 2015
Copyright: © 2015 Knör et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The authors have no support or funding to
report.
Competing Interests: The authors have declared
that no competing interests exist.
Conclusion
The present study shows a significant frequency of high-risk type HPV16 in antrochoanal pol-
yps. Absence of oncogenic transformation or correlation of the HPV-status with clinical data
suggests a latent superinfection, possibly because of anatomical proximity to the oropharynx.
Introduction
Polyposis nasi et sinuum is a common disease affecting 1–4% of the general population [1–3].
It is defined as outgrowths of nasal cavity and paranasal sinus mucosa caused by allergic or
chronic inflammation [4]. Generally, these outgrowths are considered to encompass predomi-
nant allergic- and chronic-inflammatory nasal polyps, here summarized as inflammatory nasal
polyps. Antrochoanal polyps represent with 3–6% a minority of all nasal polyps [5, 6]. Due to
this low prevalence they have so far not been studied extensively.
Nasal polyps are characterised as multifocal polypoid mucosal swellings, typical bilateral
and arising mainly from the middle meatus and ethmoid sinus region. They occur more fre-
quently in patients with persistent asthma, aspirin-exacerbated respiratory disease or cystic
fibrosis and often show an allergic background [2, 4]. Furthermore, they are regularly associ-
ated with chronic sinus infection [7, 8]. The average age of patients with NP is 50 [9, 10]. Their
histopathological structure is composed of stromal and subepithelial oedema as well as mixed
inflammatory cell infiltration, of which more than 60% are eosinophils, along with neutrophils,
mast cells and activated T- cells [1, 11]. The respiratory epithelium is usually intact and exhibits
frequently goblet cell hyperplasia.
In contrast, characteristic antrochoanal polyps usually constitute a larger solitary unilateral
mass. They originate from the maxillary sinus, pass through the nasal cavity, extend into the
choanae and further into the nasopharynx. Antrochoanal polyps consist of two components, a
cystic antral and a solid polypoid part, linked by a long stalk. Patients suffering from antro-
choanal polyps are more commonly children and young adults, with an average age of 27 in
our cohort and other studies [9, 10]. There is a lack of other risk factors or associated diseases.
It is noteworthy that allergic diseases seem to play no significant role in the pathogenesis of
antrochoanal polyps [12–14]. Accordingly they do not show morphological features typical for
allergy-associated inflammatory nasal polyps [12]. Antrochoanal polyps are histologically
characterized by firm fibrotic stroma showing high vascularisation with degenerative endothe-
lial cells and stromal multinucleated giant cells [15]. They are mainly infiltrated with plasma
cells and less eosinophils [15–17]. Compared to nasal polyps, antrochoanal polyps present no
goblet cell hyperplasia though alterations of the ciliated epithelium are common. Even squa-
mous cell metaplasia may be seen in antrochoanal polyps [15, 18].
Although sinonasal polyposis is a well-investigated entity, the aetiology still remains
unclear. To date, quite a few studies were carried out screening nasal polyps for causative fac-
tors, including human papillomavirus (HPV) [19–23]. HPV infections are related to the gene-
sis of various benign and malignant human neoplastic diseases, for example cervical cancer
[24, 25]. Likewise a subgroup of oropharyngeal cancer is increasingly recognized to be caused
by a persistent infection with high risk HPV [26, 27].
Between 2000 and 2014 only six studies investigating the association of HPV with nasal pol-
yps and sinonasal mucosa have been published. The results are highly inconsistent and showed
prevalence of HPV-DNA in nasal polyps ranging from 0% to 40%, while no viral DNA was
found in healthy controls [21, 22, 28–31].
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Obviously data concerning the prevalence of HPV in sinonasal polyposis is lacking. Previ-
ous studies have not investigated subgroups separately, so no references exist about a possible
association of HPV in particular with antrochoanal polyps. Therefore, the current study inves-
tigated the HPV frequency in a large series of inflammatory nasal polyps and antrochoanal pol-
yps via well-established HPV-polymerase chain reaction (PCR) arrays. To provide further
information about the localisation and activity of viral infection HPV 16 and p16, a biomarker
for HPV induced cancer, immunohistochemistry, as well as p16 western blot was performed.
Material and Methods
Tissue samples
166 archived fresh frozen specimens of nasal polyps from 2008 to 2012 were analysed. Overall,
antrochoanal polyps were obtained from 39 patients, between 2000 and 2012. 31 of these were
paraffin-embedded archive material from the Institute of Pathology, Friedrich-Alexander Uni-
versity of Erlangen-Nürnberg. Sixteen fresh frozen antrochoanal polyps were collected from
patients who underwent surgical treatment at ENT-Hospital, Head and Neck Surgery, Univer-
sity of Erlangen-Nürnberg. There was an overlap of eight antrochoanal polyps which were
available as fresh frozen as well as paraffin-embedded tissue (S1 Table, Antrochoanal Polyps).
Of eight patients fresh frozen as well as paraffin-embedded tissue was available. Fifty-two fresh
frozen nasal turbinates specimens with clinically normal mucosa served as control tissues.
Demographic data such as sex, age, smoking/alcohol and allergic diseases was collected. Alco-
hol consumption and smoking was categorized as yes, if current daily, and as no, if occasion-
ally, never or former. The Ethics Committee of the University of Erlangen-Nürnberg approved
the utilisation of patient tissue for research purposes (No. 3201 and 4433). All participants
were informed and gave their written informed consent.
DNA extraction
Genomic DNA (gDNA) from paraffin-embedded tissue was extracted by using peqGOLD Tis-
sue DNAMini Kit (C-Line) provided by peqlab (Erlangen, Germany) following the manufac-
turer’s protocol. DNA isolation and purification of cryopreserved tissue was conducted with
AquaGenomic™ reagent provided by MoBiTec GmbH (Göttingen, Germany) according to the
manufacturer’s instructions. DNA concentration was evaluated using standard photometer
and afterwards adjusted to 50–200 ng/μl.
DNA detection and HPV-typing
The PCR assays used were three broad spectrum primer sets, namely established GP5+/6
+ assay, short PCR fragment (SPF) PCR and E6 Nested Multiplex PCR (NMPCR) [32–35].
Furthermore type specific primers for HPV11 and HPV16 were applied [36]. The GP5+/6
+ PCR were used for HPV-detection in frozen and paraffin-embedded tissues. The SPF PCR
Assay was used especially for paraffin-embedded tissues. In addition, NMPCR was performed
on gDNA extracted from frozen tissue. It consists of a primary amplification with a set of
broad spectrum E6/7 primer, followed by nested- PCR with four cocktails of type specific prim-
ers, added together aiming for 18 HPV types [35]. Samples positive for GP5+/6+-, SPF- or
NM-PCR were additionally evaluated with type specific primers for HPV11 and HPV16 [36].
To assess the quality of DNA PCR targeting β2-microglobulin gene was amplified (sense 5’-
TCCAACATCAACATCTTGGT-3’, antisense 5’-TCCCCCAAATTCTAAGCAGA-3). For
NM- and SPF-PCR Qiagen HotStarTaq Master Mix Kit (Qiagen, Hilden Germany) and the
qPCR Core Kit SYBR1 Green I No ROX (Eurogentec, Cologne Germany) were used. PCRs
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were implemented with the iCycler (Biorad, München, Germany). Distilled water and DNA
from reliable HPV negative tissue served as negative controls. Three HPV- positive oropharyn-
geal carcinomas were included as positive controls. The amplicons were detected by gel electro-
phoresis on 2.5% agarose gel and analysed with the Lumi-Imager (Roche Applied Science,
Mannheim, Germany). HPV type identification was pursued by direct sequencing analysis
conducted by LGC Genomics GmbH (Berlin, Germany) with primer GP6+ [33]. The
sequence-evaluation was performed with BLASTN program (NCBI).
Immunohistochemistry (IHC)
IHC on paraffin embedded sections was carried out with ImmPRESS™Universal Antibody Kit
(Vector Laboratories, Inc., Burlingame, USA). To make the epitopes available for antibody
binding the sections underwent deparaffinization and heat-mediated antigen retrieval, using
Vector1 Antigen Unmasking Solution pH 6 (Vector Laboratories, Inc., Burlingame, USA) at
95°C for 20 minutes. The reduction of background staining was achieved by covering the sec-
tions for 10 minutes with BLOXALL™ Endogenous Peroxidase and Alkaline Phosphatase
Blocking Solution (Vector Laboratories, Inc., Burlingame, USA), followed by protein block
with 2.5% horse serum. The antibodies HPV16 E6/18 E6 (C1P5) monoclonal mouse antibody
(Santa Cruz Biotechnology, Inc., Heidelberg, Germany) and p16 (JC8) monoclonal mouse anti-
body (Santa Cruz Biotechnology, Inc., Heidelberg, Germany) were applied, both additionally
in Pierce1 Immunostain Enhancer (Thermo Fisher Scientific, Bonn, Germany) and incubated
over night at 4°C. A nonspecific antibody (Cell Signaling Technology, Inc., Danvers, USA)
served as negative control. Afterwards the universal secondary antibody reagent was applied.
Antigens were stained with Chromogen LinRed HRP-Substrat (Linaris, Dossenheim, Ger-
many). Counterstaining was performed with haemalaun. The sections were covered with
Aquatex1 (Merck KGaA, Darmstadt, Germany).
Western Blots
The homogenisation (T25 Basic, IKA Labortechnik, Staufen, Germany) of 30–50 mg of each
tissue sample was accomplished in 1.0 mL lysis buffer [50 mmol/L Tris, pH 7.4; 300 mmol/L
NaCl; 10 mmol/L EDTA; 1% NP40; 0.1% Triton-X100; 0.1% SDS; protease inhibitor cocktail
Complete1 (Roche, Mannheim, Germany)]. Afterwards they were incubated at 4°C for 2
hours and centrifuged at 16000g for 1 hour. The total protein concentration was determined
with bicinchoninic acid assays (Thermo Fisher Scientific, Bonn, Germany). After denaturation
through 5 minutes at 90°C with SDS loading buffer including mercaptoethanol, 50 μg of lysate
was applied on 12% Criterion™ XT Bis-Tris Precast Gel (Bio-Rad, München, Germany) and
transferred to nitrocellulose membranes (Protran-BA-83, Schleicher & Schuell). The blotting
control was Ponceau-S stained and immunostaining of β-Actin reference protein (monoclonal
rabbit antibody against β-Actin, clone 13E5, New England Biolabs GmbH Frankfurt, Ger-
many) served as control for the loading amount of protein. The primary antibody for detection
was the monoclonal mouse antibody against p16 (clone JC8, Santa Cruz Biotechnology, Inc.,
Heidelberg, Germany), followed by the secondary antibody, a peroxidase-labeled anti-mouse
IgG, F(ab’)2 antibody (KPL, Gaithersburg, USA). The blot was incubated with SuperSignal1
West Dura Extended Duration Substrate (Thermo Fisher Scientific, Bonn, Germany) and the
signals were detected with the Lumi-Imager (Roche Applied Science, Mannheim, Germany).
Statistical analysis
To reveal differences between subject attributes or clinical data, as sex, smoking, alcohol con-
sumption, allergic background and HPV- status, these variables were analysed by non-
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parametric Kruskal-Wallis analysis with post hoc multiple comparison rank analysis, non-
parametric Mann-Whitney U test and chi-square test, as required. The statistical analysis was
implemented using STATISTICA provided by StatSoft1 GmbH (Hamburg, Germany). P-val-
ues less than 0.05 were considered statistically significant.
Results
53.8% HPV-positive antrochoanal polyps
In all 257 obtained tissue specimens (166 nasal polyps, 39 antrochoanal polyps and 52 nasal
turbinates) gDNA was extracted and studied by broad spectrum PCR assays GP5+/6+, SPF
and NMPCR, relative to tissue fixation method (see details in material and methods). Repre-
sentative findings of GP5+/6+ results are depicted in Fig 1.
Overall HPV-DNA presence was detected in 15.1% of nasal polyps, 53.8% of antrochoanal
polyps and 5.8% of nasal turbinates and therefore considered HPV positive [Table 1]. High sig-
nificance (p< 0.001) was demonstrated in statistical analysis for 5.8% HPV-positive control
tissues, as well as 15.1% HPV-positive nasal polyps in comparison to 53.5% HPV-positive
antrochoanal polyps. No statistical significance was detected between nasal polyps and nasal
turbinates (p = 0.08). The genotype distribution found in nasal polyps was high risk type
HPV16 in 76%. In addition, 8% high risk type HPV56, 8% low risk type HPV11 and 8%
HPV11/16 co-infection was found. Within the HPV- positive antrochoanal polyps, the pre-
dominant type was HPV 16 in 61.9%, followed by HPV11/16 co-infections in 23.8% and
HPV11 single infection in 14.3%. Identified HPV genotypes in nasal turbinate specimens were
dead level HPV16, HPV11 and HPV11/16 co-infection. Based on according results of HPV-
detection in specimens of antrochoanal polyp where paraffin-embedded as well as cryopre-
served tissue was available the results are not separately listed according to tissue fixation
method. For further information, see supplementary data (S1 Table. Antrochoanal Polyps).
Table 1 shows the number of all obtained tissue specimens and exact number and percent-
age of HPV- positive samples of antrochoanal polyps (ACP), nasal polyps (NP) and nasal tur-
binates (NT). Furthermore, it shows the exact number and percentage of detected HPV types
for each tissue group.
These findings support the assumption that antrochoanal polyps constitute a distinct sub-
group of nasal polyps. In contrast, the majority of sinonasal polyposis, i.e. nasal polyps does
not show a significant higher HPV-association than control tissue, pointing out that there is no
aetiological association.
Positive staining for HPV 16 E6 protein in epithelial cell layers of HPV-
positive nasal- and antrochoanal polyps
To locate the virus HPV 16 E6 protein immunohistochemistry of HPV-positive nasal- and
antrochoanal polyps was performed. In all presented cases discontinuous cell clusters stained
Fig 1. GP5+/6+ PCR.Representative extraction of broad spectrum PCR with GP5+/6+ primer. Three of
twelve antrochoanal polyps (ACP) are showing clear bands, and three further weak bands. No bands are
visible in negative controls (NK) and the most intense band is present in oropharyngeal carcinoma (OPC) as
positive control.
doi:10.1371/journal.pone.0141722.g001
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positive, limited to the epithelium (Fig 2A). In antrochoanal polyps the stained regions were
mostly apparent in epithelial sections showing epithelial changes, such as stratification. The
signals were located in nuclei and cytoplasm. Within the epithelium the signals frequently
occurred in middle and apical cell layers, seldom in basal cell layers. The stained regions were
mostly apparent in epithelial sections also showing epithelial changes, as stratification and
ciliumdegeneration. The stroma consisted of firm and fibrotic tissue and showed minor inflam-
matory cell infiltration (Fig 2B and 2C). In nasal polyps cytoplasmatic and intranuclear signals
were detected in all cell layers, without clear accentuation. In the stained regions no signs of
epithelial stratification or degeneration could be found. Beyond the epithelial signals also cells
near to the basement membrane in the oedematous stroma stained HPV16 positive. There was
an obvious subepithelial infiltration of inflammatory cells in NP (Fig 2D and 2E). It is notewor-
thy that the signals found in antrochoanal- and nasal polyps were not detectable using standard
staining procedure without immunostain enhancer, indicating a very low level of E6 protein.
P16 immunohistochemistry shows weak signals in epithelial layers of
HPV-positive antrochoanal polyps
To evaluate p16 expression of HPV-positive and -negative nasal- and antrochoanal polyps,
p16-IHC was performed, also with enhancer staining. The p16-IHC showed a similar sectional
staining in HPV-DNA positive samples as we have seen in HPV16-E6-IHC. Compared to
HPV16-E6 staining the signals were weaker and irregularly distributed within the epithelium
but unequivocally identifiable. The detected signals were predominantly intranuclear (Fig 3). It
has to be mentioned that p16 staining was only positive in five cases of antrochoanal polyps,
with strong HPV-DNA positivity. In nasal polyps and nasal turbinates p16-IHC was negative.
In western blot p16 is traceable without significant increase in all tissue
specimens
The analysis of the cellular protein p16 with western blot was performed additionally to immu-
nohistochemistry of HPV-positive and -negative nasal- and antrochoanal polyps in compari-
son to negative control tissue and oropharyngeal carcinomas. It was performed because of the
slight signal strength revealed in IHC and because it is giving a hint about p16 amount. HPV-
positive carcinomas showed the most intense bands pointing out a highly increased p16
expression, also shown by Hoffmann, M., et al., 2010 [37]. In contrast no p16 bands were visi-
ble in HPV-negative carcinomas. Weak bands were traceable in HPV-positive antrochoanal
polyps, indicating a slightly elevated p16 expression in strong HPV-positive antrochoanal pol-
yps. Nasal polyps and nasal turbinates showed occasional weak bands in HPV-negative and
positive cases. Altogether the detected p16 expression in nasal polyps, antrochoanal polyps and
Table 1. HPV presence.
HPV-type risk-type ACP NP NT
Total (n = 39) Total (n = 166) Total (n = 52)
N % N % N %
Total 21 53.8 25 15.1 3 5.8
11 low 3 14.3 2 8 1 33.3
16 high 13 61.9 19 76 1 33.3
11/16 low/high 5 23.8 2 8 1 33.3
56 high 0 0 2 8 0 0
doi:10.1371/journal.pone.0141722.t001
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nasal turbinates seems to be on a regular level. The loading control with β-Actin reference pro-
tein was mainly comparable in all lines (Fig 4).
Association of HPV status and demographic data
Our clinical series was composed of 166 nasal polyps, 39 antrochoanal polyps and 52 nasal
turbinates as control tissue. The statistical analysis referred to the collected characteristics
Fig 2. HPV Immunohistochemistry. IHC Overview of a representative HPV-positive antrochoanal polyp
with HPV16 staining (A). HPV16 E6 protein staining of a representative HPV-positive antrochoanal polyp,
relevant epithelial region shown (B) with corresponding negative control (C). HPV16 E6 protein staining of a
representative HPV-positive nasal polyp, relevant epithelial region shown and subepithelial stained cells (D)
with corresponding negative control (E). Discontinuous epithelial cell clusters stained positive in HPV-positive
antrochoanal- and nasal polyps.
doi:10.1371/journal.pone.0141722.g002
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HPV- status, sex, age, smoking, alcohol consumption and allergic background, inter- and
intra-group [Table 2].
Table 2 shows the demographic data and characteristics of nasal polyps (NP), antrochoanal
polyps (ACP) and nasal turbinates (NT) used in the current study. Alcohol consumption
closely resembles Smoking.
The male-female ratio in nasal polyps was nearly 2:1 and in antrochoanal polyps 1:1, but
without statistically significant difference. Non-parametric Kruskal-Wallis ANOVA analysis of
age distribution showed statistical significance with H = 48.07 and p< 0.0001. Post hoc multi-
ple comparison rank analysis demonstrated significant differences of age among nasal- and
antrochoanal polyps, as well as among nasal polyps and nasal turbinates (Fig 5). Analysis of
age distribution restricted to HPV positive or negative cases revealed no statistically significant
changes between and within the groups. Among the multivariate statistical evaluation of smok-
ing, alcohol consumption and allergic background only alcohol consumption showed a statisti-
cally significant difference (p< 0.016) between nasal- and antrochoanal polyps, but this may
be biased by the lower mean age of patients with antrochoanal polyps. The multivariate analy-
sis of these three clinical parameters relative to HPV- status revealed no further differences
(p = 0.05). After statistical analysis none of these data could be correlated with the HPV status.
Fig 3. P16 Immunohistochemistry. Immunohistochemistry of p16 protein expression in representative HPV-positive antrochoanal polyp (A) and
corresponding negative control (B). Weak irregular spread epithelial p16-IHC staining in strong HPV-DNA positive samples. Detected signals were
dominantly intranuclear.
doi:10.1371/journal.pone.0141722.g003
Fig 4. P16Western Blot. Representative p16 western blot of HPV-positive and -negative antrochoanal
polyps (ACP), nasal polyps (NP), nasal turbinates (NT) and oropharyngeal carcinoma (OPC). Two HPV-
positive carcinomas are showing strong p16 bands. Three of four HPV-positive.
doi:10.1371/journal.pone.0141722.g004
High Frequency of HPV in Antrochoanal Polyps
PLOS ONE | DOI:10.1371/journal.pone.0141722 October 28, 2015 8 / 15
Table 2. Clinical data.
HPV-PCR ACP NP NT
Total (n = 39) Total (n = 166) Total (n = 52)
N % N % N %
Total - 18 46.2 141 84.9 49 94.2
+ 21 53.8 25 15.1 3 5.8
Age
- 29 - 46 - 33 -
+ 23 - 50 - 49 -
Gender
male - 7 17.9 89 53.6 34 65.4
+ 13 33.3 17 10.2 2 3.8
female - 11 28.2 52 31.3 15 28.8
+ 8 20.5 8 4.8 1 1.9
Allergy
yes - 7 17.9 83 50 19 36.5
+ 7 17.9 11 6.6 2 3.8
no - 11 28.2 58 34.9 30 57.7
+ 14 35.9 14 8.4 1 1.9
Smoking
yes - 3 7.7 49 29.5 23 44.2
+ 2 5.1 10 6 0 0
no - 15 38.5 92 55.4 26 50
+ 19 48.7 15 9 3 5.8
doi:10.1371/journal.pone.0141722.t002
Fig 5. Age distribution of antrochoanal- and nasal polyps. The Boxplot shows high significant difference
in age distribution of antrochoanal polyps (ACP) in comparison to nasal polyps (NP). Asterisks symbolize
significance levels of multiple comparison rank analysis (* p < 0.05; ** p < 0.01; *** p < 0.001).
doi:10.1371/journal.pone.0141722.g005
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Discussion
The major purpose of this study was to further investigate the HPV-prevalence in nasal polyps
and specially the subgroup of antrochoanal polyps, revealing unexpected significant differences.
Including 166 fresh frozen nasal polyps, 39 antrochoanal polyps and 52 nasal turbinates this
study represents one of the largest published on this topic. The number of evaluated nasal
polyp specimens in previous studies has been usually in a range of 20–48 [21, 22, 28, 30, 31],
except one Chinese publication with 204 paraffin-embedded specimens [29]. In most studies
10–36 cases of normal mucosa as controls were included, whereas one enclosed 85 hypertro-
phied turbinates [21, 22, 28–31].
Overall, the available published data reporting on HPV-DNA presence in nasal polyps have
been inconclusive, ranging from 0% to 50% HPV-frequency in NP [21, 22, 28–31]. Two Chi-
nese studies recorded 0% and 40% HPV- prevalence, respectively [28, 29]. Out of four Euro-
pean groups, two German studies failed to detect HPV in nasal polyps [21, 22], one Italian
group reported 50% HPV positive cases in 20 samples [31] and the results from a Greek group
closely resembles our findings with a HPV- prevalence of 13% in nasal polyps and 4% in adja-
cent turbinates [30]. With 53.8% HPV-frequency in antrochoanal polyps, our study shows a
significant higher association of them with HPV than inflammatory nasal polyps and nasal
turbinates.
The recently reported HPV-genotypes found in nasal polyps included high- and low risk
types, 75% were single infections [29]. Most prevalent was low-risk type HPV11 with 45.28%,
followed by high-risk HPV58 with 16.04% and high-risk HPV52 with 10.38% [29]. Zaravinos
et al, 2009, searching for HPV 6, 11, 16, 18, 33, detected neither low-risk nor high risk HPV-
types. Therefore, the detection of oncogenic HPV16 clearly dominating the genotype distribu-
tion in our study was unexpected.
The frequently used method of HPV-detection was MY09/11 PCR Assay, applied to cryopre-
served as well as paraffin-embedded nasal polyps [21, 22, 28], moreover GP5+/6+ PCR assay
[30], HPV flow through hybridisation and gene chip method [29]. Because of varying DNA-
detection methods which was used without adaptation to diverging fixation methods and to
offer a maximum of certainty, we carefully selected the PCR assays. For example, in oropharyn-
geal carcinomas the long approved general PCR Assay GP5+/6+ has been proven more sensitive
than MY09/11 PCR Assay, especially in low viral load samples [38, 39]. GP5+/6+ PCR Assay
has been applied on all specimens in our study, it targets 140 bp in the L1 gene [33, 34]. In con-
trast to the high viral load found in HPV associated oropharyngeal cancer, there merely seems
to be a low copy number in HPV-positive nasal polyps, regarding the difference in the intensity
of bands (Fig 1). Additionally, consensus primer system SPF has been implemented for paraf-
fin-embedded tissue. It has been developed with the purpose to improve the HPV detection in
paraffin-embedded samples [32] and therefore amplifies a very short fragment of 65bp in the
viral gene L1. To further increase the sensitivity, especially in detection of the assumed low viral
load and to confirm the first results, NMPCR was carried out, which provides the advantage of
simultaneous HPV type identification without sequencing [35, 40–42].
An established procedure to detect a HPV-infection causative for malignant transformation
recommends p16 immunohistochemistry and HPV-DNA detection [37, 43, 44]. P16 overex-
pression, as a result of inactivation of pRb by E7 gene product has been proposed as surrogate
marker for biologically active HPV infections in malignant neoplasia [45, 46]. It highly corre-
lates with HPV-infection [47, 48]. Furthermore, p16 overexpression can also be alternatively
induced by mechanisms otherwise than HPV interactions, as discussed in detail elsewhere [49–
51]. P16-IHC here showed inconclusive results in terms of very slight, mainly intranuclear sig-
nals in the epithelium of strong HPV positive antrochoanal polyps. Subsequently p16 western
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blot was performed, revealing no significantly elevated p16 expression in nasal- and antrochoa-
nal polyps in contrast to nasal turbinates. There was no oncogenic p16 upregulation as
reported in HPV induced malignancies, in correspondence to strong p16 staining in IHC and
intense bands in western blot [37, 45, 46], as has also been shown within the positive controls
here (Fig 4). The p16-IHC-positive cases and the slightly elevated p16 amounts in western blot
in antrochoanal polyps are more likely to be a result of present simultaneous inflammation
[50] than of HPV induced dysregulation.
The HPV16-E6-IHC is not yet a standard method. It provides a hint about viral transcrip-
tional activity and its localization. HPV16 E6 protein seems to be required for genome estab-
lishment and maintenance as extrachromosomal nuclear plasmid in host cells [52]. The results
showed weak intranuclear and cytoplasmatic signals, pointing out that the virus is present and
established in the cells with low level transcriptional activity. No high transcriptional activity
leading to oncogenic transformation is assumed. But possibly epithelial changes are induced as
stratification and ciliumdegeneration. The discontinuous staining of cell clusters can be seen as
invasion zones. Perhaps epithelial damage facilitates the infection and viral establishment. The
cells near to the basement membrane in the stroma in nasal polyps that stained HPV16 positive
can probably be HPV positive epithelial cells transmigrated into the stroma or solely an artifi-
cial staining of subepithelial inflammatory cells. For further investigations staining of basement
membrane would be a promising candidate method to prove its integrity.
Our data reported here are in line with findings about age and sex distribution of nasal- and
antrochoanal polyps, as reported in currently available literature [9, 10]. The statistical analysis
of clinicopathological data confirmed that neither age nor sex nor smoking nor alcohol con-
sumption nor allergic background correlates with the HPV status [29, 53]. The statistically sig-
nificant difference (p< 0,016) detected for alcohol consumption is highly probable a bias due
to the fact that one third of antrochoanal polyp patients are children [6, 17].
Currently there is little evidence of a causal relationship of HPV infection in nasal polyps
and their progression [29], especially when solely HPV DNA presence is proven with PCR and
sequence analysis. To identify a biological active HPV infection the verification of viral tran-
scriptional activity is required. The results of p16-IHC and western blot as well as
HPV16-E6-IHC to prove an active infection, possibly causative for proliferation, were difficult
to establish and to interpret. This is likely due the low viral load in nasal- and antrochoanal pol-
yps compared to cervical or oropharyngeal cancer. The existing surrogate marker p16 seems to
play no relevant role with respect to nasal polyps. Also HPV16-E6-IHC pointed out that there
is no relevant transcriptional activity of HPV in nasal polyps. RNA detection of E6/7oncogene
has been named method with high sensitivity to prove transcriptional activity in cervical and
oropharyngeal cancer [54–57] An important point is, that only tumours with a high viral load
seem to express E6/7 mRNA, suggesting an etiological involvement [51, 57–59]. This is also in
accordance with first results of E6/7 mRNA qPCR in this study (data not shown). There was
no E6/7 mRNA expression in HPV-positive nasal- and antrochoanal polyps detectable, postu-
lating no involvement in their development.
Taken together it is difficult to compare the varying prevalence of HPV in sinonasal polypo-
sis reported by different studies due to differences in factors such as race, geographical region,
laboratory techniques used, tissue fixation method, number of samples and choice of controls.
The results presented here clearly indicate the existence of an association of HPV with nasal
polyps, although in a lesser extent than with antrochoanal polyps. In either case this association
does not seem to initiate a proliferation or actually an oncogene transformation and is not
assumed a causative factor for their development. We propose that it rather is matter of coinci-
dental transient infection.
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